NEOPHARM PHARMACANN INVESTORS II, LLC — Form D
NEOPHARM PHARMACANN INVESTORS II, LLC of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-09. The offering totals $20.0M, of which $3.5M was reported sold. Industry: Investing.
Offering
- Filed: 2017-03-09
- Form: D
- Accession: 0001698261-17-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $3.5M
- Remaining: $16.4M
- Minimum investment: $150K
- Investors: 16
- Date of first sale: 2017-02-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-282173
Issuer
- Name: NEOPHARM PHARMACANN INVESTORS II, LLC
- CIK: 0001698261
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 300 SOUTH WACKER DRIVE, CHICAGO, IL, 60606
- Phone: 312-444-6361
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| James Patrick Barry | Executive Officer | Chicago, IL |
| Joseph Flanagan | Executive Officer | Redwood City, CA |
| James Flanigan, Jr. | Executive Officer | Chicago, IL |
| Brad Leshnock | Executive Officer | Chicago, IL |
| John Patrick Wagner | Executive Officer | Chicago, IL |
More